FourPoints Investment Managers’s Biogen BIIB Stock Holding History

FourPoints Investment Managers’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$1.67M	Sell	6,100 -1,725	-22%	-$488K	1.74%	31
2016 Q4	$2.22M	Sell	7,825 -925	-11%	-$274K	1.97%	29
2016 Q3	$2.74M	Sell	8,750 -4,200	-32%	-$1.24M	2.08%	12
2016 Q2	$3.13M	Sell	12,950 -450	-3%	-$119K	2.19%	8
2016 Q1	$3.49M	Sell	13,400 -2,500	-16%	-$660K	2.17%	18
2015 Q4	$4.87M	Buy	15,900 +4,110	+35%	+$1.18M	2.06%	21
2015 Q3	$3.44M	Buy	+11,790	New	+$3.89M	1.38%	30

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FourPoints Investment Managers's BIIB Position: Q1 2017 in Review

FourPoints Investment Managers reduced its Biogen (BIIB) stake by 22% in Q1 2017, selling an estimated $488K and leaving 6,100 shares worth $1.67M. The position accounts for 1.74% of the portfolio, ranked #31.

FourPoints Investment Managers first reported a position in BIIB in Q3 2015 and has held it in 7 quarters since. The position peaked at $4.87M in Q4 2015. 1,019 funds tracked by Wall St. Rank hold BIIB as of Q1 2017.

FourPoints Investment Managers held 6,100 shares of Biogen worth $1.67M as of Q1 2017.
FourPoints Investment Managers sold 1,725 Biogen shares in Q1 2017, an estimated $488K.
Biogen made up 1.74% of FourPoints Investment Managers's portfolio in Q1 2017, its #31 holding.
FourPoints Investment Managers first reported a position in Biogen in Q3 2015 and has held it in 7 quarters since.
FourPoints Investment Managers's Biogen position peaked at $4.87M in Q4 2015.
1,019 funds tracked by Wall St. Rank held Biogen as of Q1 2017.

Based on FourPoints Investment Managers's 13F filing for Q1 2017, filed 15 May 2017.